Teitur Trophics
PrivateLast Round
Series A
Mar 14, 2023
Total Funding Raised
$33.28M
Company Overview
Teitur Trophics is a biotechnology company that develops first-in-class peptide-based therapies for neurodegenerative diseases such as Parkinson's and Huntington's Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teitur Trophics Comparables
Compare Teitur Trophics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesper Bio ApS | 84% | |
| Johnson & Johnson | 81% | |
| Axoltis Pharma | 78% |
Teitur Trophics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 14, 2023 | ||||
| Seed | Dec 21, 2021 | ||||
| Seed | Oct 1, 2020 | ||||
| Accelerator | Jan 1, 2020 |
Teitur Trophics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovestor | Series A |
| Industrifonden | Series A |
| P53 Invest | Series A |
| Sunstone Life Science Ventures | Series A, Seed |
| BioInnovation Institute | Accelerator, Seed |
| Sound Bioventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 829% MoM, from 124 to 1.2K.
- Mar 14, 2023
$30M round led by Sound Bioventures and Sunstone Life Science Ventures.
Recent news
Latest coverage and updates
- is_developingSep 10, 2026
Teitur Trophics is developing panel of mechanism-related biomarkers that assess target engagement.
Teitur Trophics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Teitur Trophics's valuation, stock price, and market status.
Is Teitur Trophics a public or private company?
Teitur Trophics is a private company.
What is the current stock price of Teitur Trophics?
Teitur Trophics is a private company with no public stock price. No recent secondary market data is available.
How much is Teitur Trophics worth (valuation)?
Valuation information for Teitur Trophics is not publicly available.
Can I buy Teitur Trophics stock?
Teitur Trophics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Teitur Trophics's last funding round?
Teitur Trophics's most recent funding round was Series A on March 14, 2023.
Who are the main investors in Teitur Trophics?
Key investors in Teitur Trophics include Sunstone Life Science Ventures, BioInnovation Institute, Sound Bioventures.
Will Teitur Trophics IPO soon?
No public IPO plans have been announced for Teitur Trophics.
How can I track Teitur Trophics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Teitur Trophics's secondary market activity and sign up for updates.